These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 16899857)
21. Anticoagulation in Pulmonary Arterial Hypertension. Robinson JC; Pugliese SC; Fox DL; Badesch DB Curr Hypertens Rep; 2016 Jun; 18(6):47. PubMed ID: 27137522 [TBL] [Abstract][Full Text] [Related]
22. Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis. Caldeira D; Loureiro MJ; Costa J; Pinto FJ; Ferreira JJ Can J Cardiol; 2014 Aug; 30(8):879-87. PubMed ID: 24986048 [TBL] [Abstract][Full Text] [Related]
23. Pulmonary hypertension due to micro-thromboembolism from splenic and portal veins after portacaval anastomosis. Sallam M; Watson WC Br Heart J; 1970 Mar; 32(2):269-71. PubMed ID: 5440523 [TBL] [Abstract][Full Text] [Related]
24. CD44 expression in plexiform lesions of idiopathic pulmonary arterial hypertension. Ohta-Ogo K; Hao H; Ishibashi-Ueda H; Hirota S; Nakamura K; Ohe T; Ito H Pathol Int; 2012 Apr; 62(4):219-25. PubMed ID: 22449225 [TBL] [Abstract][Full Text] [Related]
25. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation]. Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182 [TBL] [Abstract][Full Text] [Related]
26. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension. Langleben D; Orfanos SE; Giovinazzo M; Hirsch A; Baron M; Senécal JL; Armaganidis A; Catravas JD Arthritis Rheum; 2008 Apr; 58(4):1156-64. PubMed ID: 18383374 [TBL] [Abstract][Full Text] [Related]
28. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Clements PJ; Tan M; McLaughlin VV; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ; Langer A; Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119 [TBL] [Abstract][Full Text] [Related]
29. Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study. Vizza CD; Badagliacca R; Sciomer S; Poscia R; Battagliese A; Schina M; Agati L; Fedele F Cardiology; 2006; 106(3):168-73. PubMed ID: 16645271 [TBL] [Abstract][Full Text] [Related]
31. [Etiopathogenesis and physiopathology in chronic thromboembolic pulmonary hypertension]. Candelera RO; Hernández TE Arch Bronconeumol; 2009 Jun; 45 Suppl 6():6-10. PubMed ID: 20542194 [TBL] [Abstract][Full Text] [Related]
32. Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension. Kang BJ; Oh YM; Lee SD; Lee JS Korean J Intern Med; 2015 Nov; 30(6):837-45. PubMed ID: 26552459 [TBL] [Abstract][Full Text] [Related]
34. Changing the prognosis of pulmonary arterial hypertension: impact of medical therapy. Chakinala MM Semin Respir Crit Care Med; 2005 Aug; 26(4):409-16. PubMed ID: 16121318 [TBL] [Abstract][Full Text] [Related]
35. Chronic thromboembolic pulmonary hypertension: role of medical therapy. Pepke-Zaba J; Jansa P; Kim NH; Naeije R; Simonneau G Eur Respir J; 2013 Apr; 41(4):985-90. PubMed ID: 23397304 [TBL] [Abstract][Full Text] [Related]